Ken Griffin Zynex Inc Transaction History

Citadel Advisors LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$9.86 - $13.74 $290,022 - $404,148	-29,414 Reduced 24.69%	89,709 $1.11 Million
Q4 2023 Feb 14, 2024	BUY	$7.1 - $10.89 $346,387 - $531,290	48,787 Added 69.36%	119,123 $1.3 Million
Q3 2023 Nov 14, 2023	BUY	$6.95 - $9.89 $351,871 - $500,720	50,629 Added 256.91%	70,336 $562,000
Q2 2023 Aug 14, 2023	BUY	$8.59 - $14.56 $169,283 - $286,933	19,707 New	19,707 $188,000
Q4 2022 Feb 14, 2023	BUY	$8.71 - $14.28 $36,773 - $60,290	4,222 New	4,222 $58,000
Q2 2022 Aug 15, 2022	SELL	$5.78 - $8.87 $698,906 - $1.07 Million	-120,918 Reduced 33.97%	235,008 $1.88 Million
Q1 2022 May 16, 2022	BUY	$5.14 - $9.35 $1.31 Million - $2.39 Million	255,090 Added 252.98%	355,926 $2.22 Million
Q4 2021 Feb 14, 2022	SELL	$8.71 - $13.77 $204,336 - $323,044	-23,460 Reduced 18.87%	100,836 $913,000
Q3 2021 Nov 15, 2021	BUY	$10.35 - $15.65 $502,254 - $759,447	48,527 Added 64.05%	124,296 $1.42 Million
Q2 2021 Aug 16, 2021	SELL	$12.25 - $14.87 $243,787 - $295,927	-19,901 Reduced 20.8%	75,769 $1.07 Million
Q1 2021 May 17, 2021	SELL	$12.28 - $19.74 $565,027 - $908,276	-46,012 Reduced 32.48%	95,670 $1.46 Million
Q4 2020 Feb 16, 2021	BUY	$11.65 - $17.94 $265,748 - $409,229	22,811 Added 19.19%	141,682 $1.91 Million
Q3 2020 Nov 16, 2020	BUY	$12.98 - $25.98 $1.4 Million - $2.8 Million	107,829 Added 976.54%	118,871 $2.07 Million
Q2 2020 Aug 14, 2020	SELL	$9.06 - $23.49 $5,753 - $14,916	-635 Reduced 5.44%	11,042 $275,000
Q1 2020 May 15, 2020	BUY	$7.2 - $13.09 $84,074 - $152,851	11,677 New	11,677 $129,000

110

9.04M

31.4K

Ticker ZYXI
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 37,453,400
Market Cap $290M
Description
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.